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Mechanisms responsible for atrioventricular (AV) block
during acute inferior myocardial infarction are only par-
tially understood. Increased parasympathetic tone is the
factor usually postulated; however, persistence of AV
block after atropine administration is frequently ob-
served. Adenosine, an endogenous ischemic metabolite,
has well established depressant effects on AV node con-
Second and third degree atrioventricular (AV) block has
been observed in 10 to 33% of patients with acute inferior
infarctions (1-4). These conduction abnormalities are as-
sociated with a normal QRS complex in conducted or junc-
tional escape beats, suggesting that the site of block is the
AV node (5). The genesis of ischemia-induced AV node
block has been attributed to a transient increase in parasym-
pathetic activity (6- 8). However , atropine is often unsuc-
cessful in abolishing heart block during acute inferior in-
farction (l,7).
An alternative mechanism to account for ischemia-in-
duced AV node block is the production of ischemic metab-
olites with negative dromotropic effects (9). Adenosine, an
endogenous metabolite that accumulates in the interstitium
during hypoxia and ischemia (10-12) , mediates the de-
pressant effects of hypoxia and ischemia on AV node con-
duction in experimental preparations (13-15). Recently,
adenosine has also been shown to depress AV node con-
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duction. In this report, an episode of atropine-resistant
AV block was reversed by aminophylline, a competitive
adenosine antagonist, in a patient with an acute inferior
myocardial infarction. This observation suggests a role
for adenosine in the mediation of ischemia-induced AV
node block.
(J Am Coli Cardiol 1986,'8:1232-4)
duction in humans (16,17). The negative dromotropic effect
of adenosine is mediated through an extracellular receptor
site (18). For example, AV node block , induced by occlu-
sion of the canine AV node artery and potentiated by in-
hibition of extracellular adenosine uptake , can be com-
pletely reversed through competitive antagonism of the
adenosine receptor (13).
In this report, we demonstrate the reversal of atropine-
resistant AV node block during inferior infarction with ami-
nophylline, a competitive adenosine antagonist. This ob-
servation suggests a role for adenosine in the mediation of
ischemia-induced AV node block in humans.
Case Report
A 62 year old black woman with a history of insulin-
dependent diabetes mellitus and well controlled hyperten-
sion was admitted 3 days after the onset of light-headedness,
weakness and fatigue unaccompanied by chest pain, nausea ,
flushing or diaphoresis. An electrocardiogram at the time
of admission revealed a new Q wave in lead III, ST elevation
in leads III and aVF and complete heart block (narrow QRS
complex) with a junctional escape rate of 50 beats/min .
Metoprolol, 50 mg orally four times a day, had been dis-
continued by the patient 3 days before admission . Serum
creatine kinase rose to 472 U/liter (normal 0 to 204 Ulliter)
with an MB fraction of 6%. On day 1, atropine, 2 mg
intravenously was administered without any effect on AV
node conduction.
Response to aminophylline. On day 3, the patient con-
tinued to exhibit third degree and 2: 1 second degree AV
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A. Pre-Aminophylline
B. Post-Aminophylline 14.3 "g/ml
Figure 1. Reversal of atrioventricular (AV) block by amino-
phylline. A, 2: I AV block. B, Restoration of normal AV con-
duction after aminophylline. Arrows denote P waves. Note that
there was a 0.5 mm increase in ST segment elevation in B com-
pared with A which was not associated with symptoms of myo-
cardial ischemia. SCL = sinus cycle length.
node block. Aminophylline, 400 mg intravenously admin-
istered over 30 minutes, led to complete resolution of AV
block (that is, 1: 1 AV conduction) (Fig. 1). A serum the-
ophylline level obtained at the resolution of AV block was
14.3 jLg/mJ. High grade AV block, however, recurred 10
hours after its initial resolution with a theophylline level of
8.5 jLg/mJ.
By day 5, high grade AV node block had continued
unabated. Atropine, 2 mg intravenously, again failed to
resolve AV block (Fig. 2). Over the course of day 6, the
level of AV block progressively diminished (that is, higher
ratios of Wenckebach block) with complete spontaneous
resolution by day 7.
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Figure 2. Failure of atropine to reverse atrioventricular (AV)
block. A, 2: I AV block. B, 2: I AV block persists after atropine
administration. Arrows denote P waves. SCL = sinus cycle length.
properties and potential mechanisms of action, It compet-
itively antagonizes the negative dromotropic action of aden-
osine by blocking extracellular adenosine receptors (18). In
addition, it is known to inhibit phosphodiesterase activity
and the release of endogenous catecholamines from sym-
pathetic nerve terminals as well as the adrenal medulla
(19-21). Thus, a sympathomimetic action of aminophylline
might also contribute to the resolution of heart block. Sev-
eral present and prior observations, however, suggest that
the primary action of aminophylline is adenosine antago-
nism rather than sympathomimetic potentiation. First, in the
presence of aminophylline, the sinus cycle length did not
shorten at a time when AV conduction improved, suggesting
the absence of catecholamine effect on the sinus node. Sec-
ond, the serum concentration of theophylline associated with
the resolution of AV block (14.3 jLg/ml or 7.7 x 1O-5M)
is below the threshold concentration required to release cate-
cholamines or increase tissue cyclic adenosine monophos-
phate (cAMP) content (22). Within the concentration range
observed in our patient, Sollevi et aJ. (23) found that plasma
catecholamine levels were not changed by theophylline.
Finally, aminophylline-induced reversal of the effects of
exogenous adenosine, hypoxia and ischemia on AV con-
duction has been shown to occur in the presence of beta-
adrenergic blockade (13,14,16,18).
Mechanisms of bradyarrhythmias. In addition to ex-
perimental data, the observed electrophysiologic effects of
adenosine in humans are consistent with adenosine media-
tion of ischemia-induced intranodal block. Intravenously
administered adenosine produces an intranodal block pre-
ceded by progressive prolongation of the AH interval (16,17).
His bundle recordings during acute inferior wall ischemia
reveal strikingly similar findings (24).
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Discussion
The findings in this study demonstrate that aminophyl-
line, a competitive adenosine antagonist, can reverse atro-
pine-resistant AV block that accompanies acute inferior in-
farction. Several observations support the hypothesis that
endogenous adenosine rather than enhanced parasympa-
thetic tone mediates AV block in this setting. Signs of ex-
cessive parasympathetic activity, such as nausea, flushing
and diaphoresis, were absent at the time of AV block. Most
importantly, atropine failed to reverse AV block, strongly
suggesting that the block was not parasympathetically me-
diated.
Pharmacologic actions of aminophylline. Aminophyl-
line is a theophylline derivative with multiple pharmacologic
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Before the present adenosine hypothesis, the origin of
intranodal heart block and sinus bradycardia in acute inferior
myocardial infarction was attributed to a transient increase
in parasympathetic overactivity (6-8). In the first few hours
after infarction, symptoms associated with enhanced para-
sympathetic activity such as nausea, vomiting and diapho-
resis are often observed. AV block under these conditions
may be mediated through activation of intramyocardial va-
gal afferents on the diaphragmatic wall of the heart with
reflex discharge through vagal fibers around the sinoatrial
and AV nodes (25,26). In the early phase of infarction,
normal AV conduction can usually be restored by atropine
administration, supporting a role for parasympathetic
overactivity (6). However, in our patient, and in almost all
patients with AV node block more than 6 hours after the
onset of symptoms, atropine is ineffective, strongly sug-
gesting an alternative mechanism (l,7).
Blood flow to the AV node is usually supplied by the
right coronary artery (4). Postmortem histologic examina-
tion of the AV node in patients demonstrating AV node
block after right coronary occlusion and inferior infarction
has revealed minimal if any damage (9). This observation
is consistent with the hypothesis that a short-term accu-
mulation of an endogenous metabolite, such as adenosine,
might mediate ischemia-induced AV node block (9).
A limitation of this study was that invasive His bundle
recordings were not obtained to specifically exclude the
presence of intra-Hisian block.
Conclusions. The data in our case report, in conjunction
with previous experimental observations, support a role for
adenosine independent of enhanced parasympathetic tone in
the mediation of ischemia-induced AV node block. More-
over, the development of more potent and specific adenosine
antagonists would further elucidate the extent to which aden-
osine underlies the genesis of these bradyarrhythmias. Such
antagonists may prove to be the treatment of choice for
symptomatic ischemia-induced bradyarrhythmias. Although
well tolerated in our patient, aminophylline, like any agent
that might increase chronotropic response, can potentially
excerbate myocardial ischemia and therefore should be ad-
ministered with considerable caution.
We express our gratitude to Elizabeth Howk for the preparation of the
manuscript.
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